Background: Continuous intravenous (IV) morphine is commonly used in ventilated neonates. Oral route is theoretically feasible but data on oral morphine in ventilated premature infants are lacking.
Objective: To assess the efficacy, efficiency, and tolerability of a continuous intravenous to oral morphine switch protocol.